3.100
+6,90%
2026-10-19
Fundamental Analysis
31 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +9.2% | -35.1% | 1 / 3 | +26.4% | -5.23 pp | -0.16 pp | +1.7% | 1.07 | 14.43 | 337 | +26,4% | 4,9 | +13,9% | 14.43 | 16.17 | −10,8% |
| Pts | 0 | 0 | 4 | 12 | 0 | 4 | 0 | 6 | 8 | |||||||
Valuation annotation:Price: 3.100 (close price on 2026-10-19)EPS (TTM): 214,9
Financial charts
1.Revenue & growth
VND bn337Q2/26
1.Revenue & growth
VND bn337Q2/26
2.Profit & growth
VND bn4,75Q2/26
3.Profit mix (Penman)
VND bn20,8Q2/26
4.Margins & cost structure
%6.5%Q2/26
5.Returns & cash cycle
% · days1.4%Q2/26
6.Earnings quality & cash
VND bn-122Q2/26
7.Asset structure
VND bn3.103Q2/26
8.Funding & debt health
VND bn · times3.103Q2/26
9.Revenue backlog
VND bn470Q2/26
10.Valuation
times · %15,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %63Q2/26
Adjusted EPS growth, latest quarter
9.2%
Average adjusted EPS growth, 3 quarters
-35.7%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26